Trinity Biotech | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Bayer EUR 982.42M 0 2025-09
Bio-Rad Laboratories USD 26.97M 90K 2025-09
EDAP TMS EUR 37.39M 0 2025-09
J&J USD 2.41B 584K 2025-09
Mesa Laboratories USD 349.53M 3.53M 2024-09
OraSure Technologies USD 0 0 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12
Siemens EUR 780.74M 6.33M 2025-12
Surmodics USD 716K 4K 2024-09
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Tosoh JPY 310.36M 5.45M 2025-12
Trinity Biotech USD 385.2M 382.82M 2025-06
Veracyte USD 79.05M 377K 2025-12


Trinity Biotech Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.